Projects per year
Fingerprint
Dive into the research topics where Kah-Whye Peng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Next Generation TOP1 Inhibition for the Treatment of Uterine Serous Carcinoma
Kaufmann, S. H. (PI), Bell, D. (CoPI), Bible, K. C. (CoPI), Cliby, W. A. (CoPI), Couch, F. F. J. (CoPI), Fields, A. P. (CoPI), Galanis, E. (CoPI), Goode, E. L. (CoPI), Haluska, P. R. J. (CoPI), Hartmann, L. C. (CoPI), Karnitz, L. M. (CoPI), Keeney, G. (CoPI), Knutson, K. L. (CoPI), Lengyel, E. (CoPI), Lingle, W. L. (CoPI), Long, H. (CoPI), Sherman, M. M. E. (CoPI), Moriarity, B. S. (CoPI), Block, M. S. (CoPI), Oberg, A. L. (CoPI), Peng, K.-W. (CoPI), Shridhar, V. (CoPI) & Weroha, S. (CoPI)
9/1/09 → 8/31/25
Project: Research project
-
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
Bakkum-Gamez, J. N. (PI), Block, M. S. (CoPI) & Peng, K.-W. (CoPI)
5/4/17 → 4/30/18
Project: Research project
-
Phase 2: NIS proteins with altered anion specificity
Suksanpaisan, L. (PI), Peng, K.-W. (CoPI) & Russell, S. J. (CoPI)
5/1/17 → 3/31/20
Project: Research project
-
-
4th International Conference on Oncolytic Viruses as Cancer Therapeutics
Peng, K.-W. (PI)
12/22/06 → 11/30/07
Project: Research project
-
Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12
Jiang, H., Nace, R., Carrasco, T. F., Zhang, L., Peng, K. W. & Russell, S. J., Mar 25 2024, In: Journal for ImmunoTherapy of Cancer. 12, 3, e008307.Research output: Contribution to journal › Article › peer-review
Open Access -
Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses
Jiang, H., Nace, R., Ariail, E., Ma, Y., McGlinch, E., Ferguson, C., Fernandez Carrasco, T., Packiriswamy, N., Zhang, L., Peng, K. W. & Russell, S. J., Jan 3 2024, In: Molecular Therapy. 32, 1, p. 241-256 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
Muñoz-Alía, M., Nace, R. A., Balakrishnan, B., Zhang, L., Packiriswamy, N., Singh, G., Warang, P., Mena, I., Narjari, R., Vandergaast, R., Peng, K. W., García-Sastre, A., Schotsaert, M. & Russell, S. J., Feb 2024, In: mBio. 15, 2Research output: Contribution to journal › Article › peer-review
Open Access -
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses
Smith, K. E. R., Peng, K. W., Pulido, J. S., Weisbrod, A. J., Strand, C. A., Allred, J. B., Newsom, A. N., Zhang, L., Packiriswamy, N., Kottke, T., Tonne, J. M., Moore, M., Montane, H. N., Kottschade, L. A., McWilliams, R. R., Dudek, A. Z., Yan, Y., Dimou, A., Markovic, S. N. & Federspiel, M. J. & 3 others, , 2023, In: Frontiers in immunology. 14, 1279387.Research output: Contribution to journal › Article › peer-review
Open Access -
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine
Peng, K. W., Carey, T., Lech, P., Vandergaast, R., Muñoz-Alía, M., Packiriswamy, N., Gnanadurai, C., Krotova, K., Tesfay, M., Ziegler, C., Haselton, M., Sevola, K., Lathrum, C., Reiter, S., Narjari, R., Balakrishnan, B., Suksanpaisan, L., Sakuma, T., Recker, J. & Zhang, L. & 10 others, , Apr 1 2022, In: Vaccine. 40, 15, p. 2342-2351 10 p.Research output: Contribution to journal › Article › peer-review
Open Access